Joint Formulary & PAD

Terbutaline (Bricanyl Turbohaler) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Terbutaline (Bricanyl Turbohaler)
Indication :
Asthma
Group Name :
SABA
Keywords :
SABA, adrenoreceptor agonists, short acting beta agonist, respiratory, asthmatics, terbutaline sulphate
Brand Names Include :
Bricanyl Turbohaler
Important Information :

Alternative low carbon DPI (Easyhaler Salbutamol is the more cost-effective treatment option)

Prescribe by BRAND.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3

Other Indications

Below are listed other indications that Terbutaline (Bricanyl Turbohaler) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Asthma.

Committee Recommendations (2)

Bricanyl Turbohaler is not a locally preferred device.

Salamol MDI is the locally preferred SABA MDI device and should be used with a spacer device.
It has a lower carbon footprint than the large volume MDIs such as Ventolin.

Salbutamol Easyhaler is the locally preferred SABA dry powder device. If an alternative dry powder is required, Bricanyl Turbohaler may be considered.

Branded prescribing of inhaler devices is recommended.

See Asthma local guidelines below

Terbutaline sulfate is not included within the local asthma guidelines.
It is considerably more costly than the salbutamol Easyhaler.
Please refer to local guidelines below